Alternative donor allogeneic transplants: Introduction

Allogeneic hematopoietic stem cell transplantation is now a 60-year-old lady, who has aged with grace, becoming more refined and sophisticated, ever evolving to better fit with the needs of a growing cancer population. Since its inception, one of the defining major limitations of this approach has been a lack of donor availability. In the last 15 years, we observed a remarkable number of advances in the procedure, chief amongst which include new possibilities for the use of alternative donors, which have dramatically broadened the application of this life-saving procedure.
Source: Seminars in Hematology - Category: Hematology Authors: Source Type: research